American Cryostem 2016 Year End Update
EATONTOWN, NJ / ACCESSWIRE / January 4, 2017 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company's year ending September 30, 2016; The Company's Total Revenue increased 75% in...
Read more









